Share Price
$109.51
snapshot March 2026
Market Cap
~$6.6B
NASDAQ-100 + TA-35
Revenue 2025
$2.95B
+7.7% Y/Y | Cloud 76%
Net Income 2025
$612M
+38.3% Y/Y | EPS $9.67
FCF 2025
$698M
FCF Margin 23.7%
AI ARR Q4 2025 Y/Y
+66%
2026 Cloud guidance: +14.5-15%
1 Company Profile
NICE is an Israeli software company founded in 1986, listed on NASDAQ (since 1996) and on the Tel Aviv Stock Exchange, with US headquarters in Hoboken, New Jersey. The company specialises in customer-experience software (CCaaS — Contact Center as a Service), AI for customer service, workforce engagement management (WEM/WFO), and fraud prevention and financial-services compliance (NICE Actimize). NICE is considered one of the "Big Four" Israeli software companies, alongside Check Point, Amdocs and CyberArk — and a global market leader in CCaaS alongside Genesys. The business operates a high-quality recurring-revenue SaaS model with strong cash generation.
| Segment | Revenue ($M) | % of Total | Y/Y Change |
|---|
| Cloud / SaaS | 2,238.4 | 76.0% | +12.8% |
| Services | 560.0 | 19.0% | -6.0% |
| Product (On-Premise) | 147.0 | 5.0% | -5.2% |
| Total | 2,945.4 | 100% | +7.7% |
Source: Form 20-F FY2025
2 Key Financial Observations
This summary is not a recommendation. It is a factual list of key financial metrics.
Performance — 3 Years ($M)
| Year | Revenue | Cloud | Net Income | EPS |
|---|
| 2023 | 2,377.5 | 1,581.8 | 338.3 | $5.11 |
| 2024 | 2,735.3 | 1,984.2 | 442.6 | $6.76 |
| 2025 | 2,945.4 | 2,238.4 | 612.1 | $9.67 |
Cash Flow & Balance Sheet ($M)
| Metric | 2024 | 2025 |
|---|
| Operating Cash Flow | 832.6 | 716.5 |
| FCF | 797.7 | 697.6 |
| FCF Margin | 29.2% | 23.7% |
| Operating Margin | 20.0% | 21.9% |
| Cash + Investments | 1,621.7 | 417.4 |
| Total Equity | 3,603.2 | 3,876.5 |
Missing data: 2021-2022 in 20-F archive, ARR breakdown by AI product, pricing of large deals.
Net Income — 3 Years ($M)
GAAP Operating Margin — Trend (%)
3 Industry & Competitive Context
Enterprise software — CCaaS + AI for customer service + WFM + Financial Compliance. A non-cyclical market with long-term contracts, although enterprise IT spend can be hit during a recession. High concentration — NICE + Genesys = Top 2 per Gartner and Forrester.
| Competitor | Product | Key Differentiator |
|---|
| Genesys | Genesys Cloud | Closest direct competitor, private |
| Five9 | Five9 Cloud | Strong in outbound calling |
| Verint | Open Platform | Competes in WFM and Compliance |
| Salesforce | Service Cloud | Entry via CRM |
| Talkdesk / Calabrio | CCaaS | Smaller players |
4 Risk Factors
| Risk | Context |
|---|
| Generative AI as a disruptor | OpenAI, Google, Amazon offer AI-based CX solutions that may present an alternative to CCaaS platforms. NICE responds with Enlighten AI (ARR +66%) |
| Cloud growth deceleration | Decline from +25.4% (2024) to +12.8% (2025). Management 2026 guidance of +14.5-15% — still below the peak |
| Legacy erosion | Services -6.0% and Product -5.2% in 2025. Cloud must compensate more and more |
| Cognigy acquisition execution ($856M) | The largest acquisition in NICE's history. Integration and customer-retention risk |
| Liquidity decline | Cash + investments fell from $1.62B to $417M — a combination of acquisition + buyback + debt repayment |
| New CEO (Russell) | First year — positive results but requires another business cycle for confirmation |
| High goodwill ($2.44B) | 48% of assets. Sensitivity to recurring impairment if performance deteriorates |
5 Analytical Lens — The Questions We Ask
In professional company analysis, the question is not "is this good?" but rather "through which lenses must this company be examined so that we do not miss what matters most?" At Bakshi Finance, every analysis passes through six lenses. The text below is not an assessment — it is the mapping of the questions this analysis is intended to answer.
This framework is intended to structure analysis, not to produce an investment conclusion.
Growth
Cloud revenue grew +12.8% in 2025 versus +25.4% in 2024 — a clear deceleration. Management 2026 guidance: +14.5-15%. Is the slowdown NICE-specific, market-wide, or technical? How much of 2026 growth is expected from Cognigy vs organic?
Profitability
Operating margin rose from 18.3% to 21.9% over two years. How much of the improvement is mix-shift versus temporary (cost savings, lower stock-based comp)? What is the reasonable ceiling — 25%? 30%?
Leverage
Minimal debt, but liquidity fell from $1.62B to $417M in 2025, primarily due to Cognigy. How much buffer is needed to execute the $600M planned buyback + continue M&A? Is $700M annual cash flow sufficient, or will debt be required?
Competitive Position
NICE + Genesys dominate the market. The real AI risk — will ChatGPT-grade bots replace customer needs or merely complement? Where does Cognigy position itself in that battle?
Management Quality
Russell in his first year as CEO. To what extent does the Cognigy acquisition fit the long-term strategy? Is aggressive buyback ($1B of active programmes) the right choice, or is it better to preserve liquidity for further M&A?
Business Complexity / Risk
NICE combines four product lines (CCaaS, AI, WFM, Actimize) across multiple regions. How to interpret 87% of revenue from the Americas — is there geographic concentration risk? How will $2.44B of goodwill (48% of assets) behave in a downturn?
6 Scenario Framework
Scenarios are descriptive, not predictive. They outline possible conditions, not expected outcomes.
These scenarios carry no probability assessment, no preferred direction, and no expectation regarding which, if any, will materialise.
Constructive Scenario — if the following conditions hold:
Management’s 2026 guidance materialises — cloud growth accelerates to 14.5-15%, AI ARR continues to show +50%+ Y/Y, Cognigy integration succeeds and adds AI Agentic revenue, and operating margins continue to improve toward 24-25%. The $600M buyback programme executes and reduces share count by 9-10%. Under these conditions, EPS continues to grow double-digit and FCF may return to $800M+.
Base Scenario — if current trends continue:
Cloud growth is stable at 12-14%, total revenue growth 7-9% (services/product deceleration continues to offset), operating margins around 22%, FCF around $700M annually. Multiples stay in the current range — the market is not rushing to re-rate SaaS at this growth pace.
Adverse Scenario — if the following risks materialise:
Generative AI disrupts CCaaS faster than expected — large customers evaluate LLM-based alternatives directly, cloud growth drops below 10%, Cognigy integration hits issues, or a recession forces IT cuts slowing new sales. Under these conditions, FCF erodes and the market prices in further deterioration.
Scenarios describe conditions, not forecasts. There is no preferred direction and no probability assessment expressed in this framework.
7 How to Think About This Company
NICE is not a typical CCaaS company — it sits at a critical intersection between a business model that worked excellently for a decade (cloud transition of contact centres) and an open strategic question (whether generative AI makes the entire category irrelevant, or strengthens it). This strategic pivot explains the current valuation — P/E of ~10×, EV/EBITDA ~7.4× — multiples that suit a value equity, not a growth SaaS. The real question in analysing NICE is not "are the numbers good" (they are — 7.7% growth, +38% net income, $700M FCF), but rather "is the business model sustainable over a 5-10 year horizon in the generative-AI era?"
The critical variables to monitor are three. First, cloud growth pace — 25% in 2024 dropped to 13% in 2025; management 2026 guidance calls for re-acceleration to 14.5-15%. If the re-acceleration doesn’t materialise, the market will infer a structural problem, not cyclical. Second, AI ARR — 66% Y/Y growth in Q4 2025 is evidence that NICE is participating in the AI revolution and not becoming its victim. The question is not just pace, but share of total revenue — as long as AI ARR remains a small part of $2.95B, disruption risk remains elevated. Third, Cognigy execution — an $856M acquisition is not trivial. If it delivers $100-150M of AI Agentic revenue in 2026 and proves future growth, it justifies itself. If not — pressure will mount for goodwill impairment.
Where the analysis may go wrong. First error — treating EPS of $9.67 as run-rate. Part of the improvement reflects share-count reduction (66.3M to 63.3M), lower stock-based comp ($146M vs $182M), and improved efficiencies. Real operating growth is more modest than EPS growth. Second error — valuing the company on historical SaaS multiples. NICE traded at P/E 96× in 2021 and 46× in 2022 — but those were bubble multiples. Normalisation to 15-20× is not a temporary drift, it is a structural reset for the entire SaaS category in a higher-rate environment and with AI uncertainty. Third error — ignoring the liquidity decline. A $1.2B drop in liquidity in one year is material, even if the reason (Cognigy + buyback) is logical. Low liquidity constrains flexibility for further M&A or crisis response.
What distinguishes professional analysis of NICE from headlines. Headlines on NICE speak of "cheap SaaS equity" or of "AI disruption". Professional analysis addresses three things: (a) what differentiates NICE’s growth from generic CCaaS growth — is NICE gaining market share or simply riding the tide; (b) the sensitivity of EPS to buyback — every $200M of buyback roughly translates to 1.8% fewer shares, about 2% additional EPS automatically; (c) the post-Cognigy scenario — is this the last acquisition or the first in a series. These are not what one buys or sells — they are what one asks before deciding.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
8 Sources & Data
| # | Source | Date | Type |
|---|
| 1 | SEC EDGAR — Form 20-F FY2025 (P1725031-00) | March 2026 | Official — SEC |
| 2 | SEC EDGAR — Form 6-K Q4 2025 (P1723501-00) | February 2026 | Official — SEC |
| 3 | nice.com — IR | Quarterly | Official — company website |
| 4 | maya.tase.co.il — Company details (NICE) | April 2026 | Official — Stock Exchange |
| 5 | NASDAQ.com — NICE quote | April 2026 | Official — Stock Exchange |
| 6 | stockanalysis.com — Multiples | April 2026 | Secondary |
Missing: 2021-2022 in 20-F archive, ARR breakdown by AI product, pricing of large deals.
